These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7531800)

  • 1. Invited letter concerning: topical aprotinin.
    Edmunds LH
    J Thorac Cardiovasc Surg; 1995 Feb; 109(2):400-2. PubMed ID: 7531800
    [No Abstract]   [Full Text] [Related]  

  • 2. Invited letter concerning: aprotinin use in pediatric cardiac operations.
    Edmunds LH
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):757-60. PubMed ID: 7682269
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical effect of aprotinin on the surgical wound in cardiac surgery.
    Tabuchi N; de Hoan J; van Oeveren W
    J Thorac Cardiovasc Surg; 1995 Feb; 109(2):399-400. PubMed ID: 7531799
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-dose and high-dose aprotinin improve hemostasis in coronary operations.
    Speekenbrink RG; Wildevuur CR; Sturk A; Eijsman L
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):523-30. PubMed ID: 8751522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical aprotinin in cardiac operations.
    O'Regan DJ; Giannopoulos N; Mediratta N; Kendall SW; Forni A; Pillai R; Westaby S
    Ann Thorac Surg; 1994 Sep; 58(3):778-81. PubMed ID: 7524457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass.
    Blauhut B; Gross C; Necek S; Doran JE; Späth P; Lundsgaard-Hansen P
    J Thorac Cardiovasc Surg; 1991 Jun; 101(6):958-67. PubMed ID: 1710008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of minimal-dose aprotinin on coronary artery bypass grafting.
    Hayashida N; Isomura T; Sato T; Maruyama H; Kosuga K; Aoyagi S
    J Thorac Cardiovasc Surg; 1997 Aug; 114(2):261-9. PubMed ID: 9270645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of high-dose aprotinin on hemostasis and blood requirement in orthotopic liver transplantation.
    Grosse H; Lobbes W; Frambach M; Ringe B; Barthels M
    Semin Thromb Hemost; 1993; 19(3):302-5. PubMed ID: 7689757
    [No Abstract]   [Full Text] [Related]  

  • 9. Aprotinin improves hemostasis after cardiopulmonary bypass better than single-donor platelet concentrate.
    Shinfeld A; Zippel D; Lavee J; Lusky A; Shinar E; Savion N; Mohr R
    Ann Thorac Surg; 1995 Apr; 59(4):872-6. PubMed ID: 7535040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invited letter concerning: aprotinin.
    Edmunds LH; Niewiarowski S; Colman RW
    J Thorac Cardiovasc Surg; 1991 Jun; 101(6):1103-4. PubMed ID: 1710007
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol).
    Bidstrup BP; Royston D; Sapsford RN; Taylor KM
    J Thorac Cardiovasc Surg; 1989 Mar; 97(3):364-72. PubMed ID: 2465457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding reduction in cardiac surgery: a combined approach.
    Bizzarri F; Carone E; Capannini G; Davoli G; Lisi G; Maccherini M; Sani G; Toscano M
    J Thorac Cardiovasc Surg; 1998 May; 115(5):1227. PubMed ID: 9605101
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation.
    Havel M; Teufelsbauer H; Knöbl P; Dalmatiner R; Jaksch P; Zwölfer W; Müller M; Vukovich T
    J Thorac Cardiovasc Surg; 1991 Jun; 101(6):968-72. PubMed ID: 1710009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aprotinin for intraoperative haemostasis.
    Tzonos T; Giromini D
    Neurosurg Rev; 1981; 4(4):193-4. PubMed ID: 6173817
    [No Abstract]   [Full Text] [Related]  

  • 15. Aprotinin: antifibrinolytic and anti-inflammatory mechanisms of action in cardiac surgery with cardiopulmonary bypass.
    Donahue MA; Price PM
    Dynamics; 2002; 13(3):16-23. PubMed ID: 12640841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprotinin for bleeding after cardiopulmonary bypass.
    Bidstrup B
    Lancet; 1990 Jun; 335(8704):1535-6. PubMed ID: 1693997
    [No Abstract]   [Full Text] [Related]  

  • 17. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
    Lu H; Du Buit C; Soria J; Touchot B; Chollet B; Commin PL; Conseiller C; Echter E; Soria C
    Thromb Haemost; 1994 Sep; 72(3):438-43. PubMed ID: 7531877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Greilich PE; Jessen ME; Satyanarayana N; Whitten CW; Nuttall GA; Beckham JM; Wall MH; Butterworth JF
    Anesth Analg; 2009 Jul; 109(1):15-24. PubMed ID: 19535691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
    Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
    Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
    Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C
    Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.